231 related articles for article (PubMed ID: 31064660)
1. Aggressive gastro-entero-pancreatic neoplasms.
Coriat R
Ann Endocrinol (Paris); 2019 Jun; 80(3):185-186. PubMed ID: 31064660
[No Abstract] [Full Text] [Related]
2. Management of gastro-entero-pancreatic neuroendocrine tumours (GEP NET): an introduction.
Van Hootegem P; Borbath I; Verslype C
Acta Gastroenterol Belg; 2009; 72(1):27-8. PubMed ID: 19402367
[No Abstract] [Full Text] [Related]
3. Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Öberg K; Knigge U; Kwekkeboom D; Perren A;
Ann Oncol; 2012 Oct; 23 Suppl 7():vii124-30. PubMed ID: 22997445
[No Abstract] [Full Text] [Related]
4. [Surgical treatments for gastroenteropancreatic neuroendocrine tumor (GEP-NET)].
Aoki T; Kokudo N
Nihon Shokakibyo Gakkai Zasshi; 2014 Dec; 111(12):2272-9. PubMed ID: 25482902
[No Abstract] [Full Text] [Related]
5. Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors.
Singh S; Moody L; Chan DL; Metz DC; Strosberg J; Asmis T; Bailey DL; Bergsland E; Brendtro K; Carroll R; Cleary S; Kim M; Kong G; Law C; Lawrence B; McEwan A; McGregor C; Michael M; Pasieka J; Pavlakis N; Pommier R; Soulen M; Wyld D; Segelov E;
JAMA Oncol; 2018 Nov; 4(11):1597-1604. PubMed ID: 30054622
[TBL] [Abstract][Full Text] [Related]
6. Gastroenteropancreatic neuroendocrine tumors: current perspectives and future challenges.
Garcia-Carbonero R
Cancer Metastasis Rev; 2014 Mar; 33(1):343-4. PubMed ID: 24357057
[No Abstract] [Full Text] [Related]
7. Recurrence in Resected Gastroenteropancreatic Neuroendocrine Tumors.
Singh S; Chan DL; Moody L; Liu N; Fischer HD; Austin PC; Segelov E
JAMA Oncol; 2018 Apr; 4(4):583-585. PubMed ID: 29543939
[TBL] [Abstract][Full Text] [Related]
8. Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres.
Frizziero M; Wang X; Chakrabarty B; Childs A; Luong TV; Walter T; Khan MS; Morgan M; Christian A; Elshafie M; Shah T; Minicozzi A; Mansoor W; Meyer T; Lamarca A; Hubner RA; Valle JW; McNamara MG
World J Gastroenterol; 2019 Oct; 25(39):5991-6005. PubMed ID: 31660035
[TBL] [Abstract][Full Text] [Related]
9. [Gastroenteropancreatic neuroendocrine neoplasms-Heterogeneity, management and perspectives of treatment and research].
Luley K; Gebauer J; Gebauer N; Tharun L; Buchmann I; Barkhausen J; von Bubnoff N; Lindner K; Keck T; Lehnert H; Schmid SM
Internist (Berl); 2020 Aug; 61(8):875-890. PubMed ID: 32676723
[TBL] [Abstract][Full Text] [Related]
10. New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.
Phan AT; Kunz PL; Reidy-Lagunes DL
Clin Adv Hematol Oncol; 2015 May; 13(5 Suppl 5):1-18; quiz 1 p following 18. PubMed ID: 26430956
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Gastroenteropancreatic Neuroendocrine Tumors.
Perez K; Chan J
Surg Pathol Clin; 2019 Dec; 12(4):1045-1053. PubMed ID: 31672293
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological characterization of gastro-entero- pancreatic neuroendocrine tumors].
Borka K
Magy Onkol; 2018 Jul; 62(2):90-97. PubMed ID: 30027936
[TBL] [Abstract][Full Text] [Related]
13. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in patients with neuroendocrine tumors.
Akerström G; Falconi M; Kianmanesh R; Ruszniewski P; Plöckinger U; ;
Neuroendocrinology; 2009; 90(2):203-8. PubMed ID: 19713712
[No Abstract] [Full Text] [Related]
14. [Gastroenteropancreatic neuroendocrine tumor microenvironment and related therapy].
Ye C; Yuan CH; Li G; Zheng L; Xiu DR
Zhonghua Wai Ke Za Zhi; 2019 Nov; 57(11):866-871. PubMed ID: 31694137
[TBL] [Abstract][Full Text] [Related]
15. Surgery for GEP-NETs.
Knigge U; Hansen CP
Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):819-31. PubMed ID: 23582921
[TBL] [Abstract][Full Text] [Related]
16. Biology and Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors.
Raj N; Fazio N; Strosberg J
Am Soc Clin Oncol Educ Book; 2018 May; 38():292-299. PubMed ID: 30231344
[TBL] [Abstract][Full Text] [Related]
17. SNM 2012 image of the year.
J Nucl Med; 2012 Oct; 53(10):23N. PubMed ID: 23028181
[No Abstract] [Full Text] [Related]
18. GEP-NETS update: a review on surgery of gastro-entero-pancreatic neuroendocrine tumors.
Partelli S; Maurizi A; Tamburrino D; Baldoni A; Polenta V; Crippa S; Falconi M
Eur J Endocrinol; 2014 Oct; 171(4):R153-62. PubMed ID: 24920289
[TBL] [Abstract][Full Text] [Related]
19. Imaging-guided precision medicine in non-resectable gastro-entero-pancreatic neuroendocrine tumors: A step-by-step approach.
Rozenblum L; Mokrane FZ; Yeh R; Sinigaglia M; Besson FL; Seban RD; Zadro C; Dierickx L; Chougnet CN; Partouche E; Revel-Mouroz P; Zhao B; Otal P; Schwartz LH; Dercle L
Eur J Radiol; 2020 Jan; 122():108743. PubMed ID: 31783345
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of Radio-Guided Surgery with ⁶⁸Gallium-DOTATATE in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors.
Sadowski SM; Millo C; Neychev V; Aufforth R; Keutgen X; Glanville J; Alimchandani M; Nilubol N; Herscovitch P; Quezado M; Kebebew E
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S676-82. PubMed ID: 26350374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]